Whitehawk Therapeutics (WHWK) Cash & Current Investments (2018 - 2025)
Historic Cash & Current Investments for Whitehawk Therapeutics (WHWK) over the last 8 years, with Q3 2025 value amounting to $287.3 million.
- Whitehawk Therapeutics' Cash & Current Investments rose 35875.21% to $287.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $287.3 million, marking a year-over-year increase of 35875.21%. This contributed to the annual value of $47.2 million for FY2024, which is 5660.16% down from last year.
- Whitehawk Therapeutics' Cash & Current Investments amounted to $287.3 million in Q3 2025, which was up 35875.21% from $209.5 million recorded in Q2 2025.
- Over the past 5 years, Whitehawk Therapeutics' Cash & Current Investments peaked at $287.3 million during Q3 2025, and registered a low of $36.8 million during Q2 2021.
- In the last 5 years, Whitehawk Therapeutics' Cash & Current Investments had a median value of $129.8 million in 2022 and averaged $132.1 million.
- In the last 5 years, Whitehawk Therapeutics' Cash & Current Investments plummeted by 5660.16% in 2024 and then surged by 35875.21% in 2025.
- Quarter analysis of 5 years shows Whitehawk Therapeutics' Cash & Current Investments stood at $149.0 million in 2021, then rose by 15.82% to $172.6 million in 2022, then tumbled by 36.92% to $108.8 million in 2023, then tumbled by 56.6% to $47.2 million in 2024, then surged by 508.14% to $287.3 million in 2025.
- Its last three reported values are $287.3 million in Q3 2025, $209.5 million for Q2 2025, and $231.1 million during Q1 2025.